2022
DOI: 10.7759/cureus.30923
|View full text |Cite
|
Sign up to set email alerts
|

Permanent Pacemaker Placement Secondary to Remdesivir Induced Bradycardia: A Case Report

Abstract: Remdesivir is approved by the FDA for the treatment of hospitalized coronavirus disease 2019 patients. It is known to be associated with transient bradycardia that resolves after discontinuation of the drug. We present a case of a 71-year-old male with a history of congestive heart failure, hypertension, and atrial flutter (rate controlled with carvedilol) presented for evaluation of worsening dyspnea, dry cough, and fatigue. His COVID-19 reverse transcription-polymerase chain reaction (RT-PCR) was positive a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 21 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?